Seizure

Texas Original Launches Elevate Beverage, Texas’ First CBG-Based Medical Cannabis Product

Retrieved on: 
Monday, January 22, 2024

Texas Original , Texas’ leading medical cannabis provider, announced today the launch of its new Elevate beverage product, the first medical cannabis product in Texas infused with cannabigerol (CBG).

Key Points: 
  • Texas Original , Texas’ leading medical cannabis provider, announced today the launch of its new Elevate beverage product, the first medical cannabis product in Texas infused with cannabigerol (CBG).
  • Elevate is designed to help offer uplifting, energizing relief for common symptoms associated with conditions that qualify for medical cannabis prescriptions under Texas’ Compassionate Use Program, including anxiety, pain, inflammation and depression.
  • Elevate, Texas Original’s first beverage product, is a one-to-one mixture containing equal parts CBG and THC, along with other potentially beneficial ingredients like ginger juice and turmeric.
  • “Elevate was purpose-built to address a need we identified within our patient base—a liquid-based, easy-dose product that works quickly,” said Nico Richardson, CEO of Texas Original.

Old Glory Bank Blasts the Federal Government's Intrusion into Americans’ Personal Banking Transactions

Retrieved on: 
Thursday, January 18, 2024

Old Glory Bank’s Co-Founder and Chief Strategy Officer, Eric Ohlhausen, blasted the Federal government’s apparent unconstitutional intrusion into Americans’ personal banking transactions, as uncovered by the Congressional Select Committee on the Weaponization of the Federal Government.

Key Points: 
  • Old Glory Bank’s Co-Founder and Chief Strategy Officer, Eric Ohlhausen, blasted the Federal government’s apparent unconstitutional intrusion into Americans’ personal banking transactions, as uncovered by the Congressional Select Committee on the Weaponization of the Federal Government.
  • According to the subcommittee, the federal government “urged large financial institutions to comb through the private transactions of their customers for suspicious charges on the basis of protected political and religious expression.”
    “Old Glory Bank is an unwavering supporter of its customers’ privacy, security and liberty.
  • If Old Glory Bank were ever asked, we wouldn’t comply.
  • To interview one of Old Glory Bank’s Senior Leaders or Co-Founders, contact Ms. Jules Wortman, at [email protected] or Kim Doster, at [email protected]

Physicians Describe "Underrecognized Neurological Emergency" in New Clinical Proceedings Paper

Retrieved on: 
Thursday, January 18, 2024

WASHINGTON, Jan. 18, 2024 /PRNewswire/ -- A lack of convulsions can make some extended seizures difficult to diagnose and treat, explains a new expert-led clinical proceedings paper from the Clinical Neurological Society of America. "Nonconvulsive Status Epilepticus: An Underrecognized Neurological Emergency" notes that, while convulsions are a clear sign of status epilepticus, not all seizures are accompanied by them.

Key Points: 
  • Not all seizures include convulsions, neurologists explain, leading to diagnosis challenges and dangerous treatment delays
    WASHINGTON, Jan. 18, 2024 /PRNewswire/ -- A lack of convulsions can make some extended seizures difficult to diagnose and treat, explains a new expert-led clinical proceedings paper from the Clinical Neurological Society of America. "
  • Nonconvulsive Status Epilepticus: An Underrecognized Neurological Emergency " notes that, while convulsions are a clear sign of status epilepticus, not all seizures are accompanied by them.
  • That's why EEGs – continuous if available, or at least rapid EEG for emergency monitoring – are essential to properly diagnose NCSE, the paper explains.
  • better identification of nonconvulsive status epilepticus, or NCSE
    the use of electroencephalograms or EEGs for diagnosis, and
    timely treatment to stop seizures.

Comanche Biopharma Closes Oversubscribed $75 Million Series B Financing to Advance Mission to Develop and Make Globally Available the First Treatment Targeting a Root Cause of Preeclampsia

Retrieved on: 
Wednesday, January 17, 2024

Preeclampsia is a prevalent and serious pregnancy complication that affects approximately 10 million women globally each year.

Key Points: 
  • Preeclampsia is a prevalent and serious pregnancy complication that affects approximately 10 million women globally each year.
  • It can lead to serious complications for both the mother and the baby, including multi-organ damage, seizures, and premature birth.
  • Currently, delivery of the baby, often very prematurely, is the only available option for stopping the progression of preeclampsia.
  • Scott Johnson, M.D., Chief Executive Officer at Comanche Biopharma, commented, “We are thrilled to have the support and validation of this top-tier investor syndicate.

Revive Therapeutics Provides Update Evaluating Bucillamine for Nerve Agent Exposure with Defence Research and Development Canada

Retrieved on: 
Tuesday, January 16, 2024

TORONTO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, today announced an update on the Company’s project evaluating Bucillamine as a potential treatment for nerve agent exposure with Defence R&D Canada – Suffield Research Centre (“DRDC”), an agency of the Canadian Department of National Defence.

Key Points: 
  • TORONTO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, today announced an update on the Company’s project evaluating Bucillamine as a potential treatment for nerve agent exposure with Defence R&D Canada – Suffield Research Centre (“DRDC”), an agency of the Canadian Department of National Defence.
  • The Company and the DRDC have finalized the research protocol and expect the project to be completed by the end of Q2-2024.
  • DRDC is investigating pharmacological compounds that can mitigate nerve agent induced brain injury.
  • Bucillamine and NAC will be evaluated to determine the effect on GABA(A) receptor endocytosis and the effect on diazepam effectiveness in terminating seizures.

Urgent call for timely, affordable access to new life-changing epilepsy treatments in Canada

Retrieved on: 
Wednesday, January 10, 2024

Although epilepsy is a highly treatable disease, more than 100,000 Canadians are unable to control their seizures with the treatment options currently funded by provincial governments in Canada.

Key Points: 
  • Although epilepsy is a highly treatable disease, more than 100,000 Canadians are unable to control their seizures with the treatment options currently funded by provincial governments in Canada.
  • Living with uncontrolled seizures has a direct impact on a person’s quality of life, including social isolation, educational prospects, career opportunities and mental health.
  • While the disease affects nearly 300,000 Canadians, it is not widely understood by the general population leading to stigma and discrimination.
  • Wouldn't that be amazing?”
    In June 2023, Health Canada approved a promising new anti-seizure medication, giving patients like Megan new hope.

Nonprofits Team Up in the Battle Against Epilepsy in Children

Retrieved on: 
Wednesday, January 10, 2024

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240110805743/en/
    Lily’s Lighthouse was founded in 2021 by Sarah-Kate Boylan, a mother seeking relief for her child, Lily, who was suffering from chronic seizures.
  • After seven years of ineffective treatment, Sarah-Kate found preliminary research suggesting functional mushrooms could help Lily with her intractable epilepsy.
  • The upcoming study will focus on the anticonvulsant properties of Reishi mushrooms and the neuroprotective and anti-inflammatory properties of Lion’s Mane mushrooms.
  • “Through this collaboration, we hope to publish outcomes of a retrospective study for the treatment of epilepsy.

Alyssa's Law Is Making Florida Schools Safer: A New Report from CENTEGIX Examines State-Wide Positive Impact of Wearable Panic Buttons in K-12 Schools

Retrieved on: 
Wednesday, January 10, 2024

ATLANTA, Jan. 10, 2024 /PRNewswire/ -- CENTEGIX, the industry leader and largest wearable safety technology provider for K-12 education, today released a new report on the impact of legislation requiring mobile panic buttons in Florida's K-12 schools. The report, Alyssa's Law: Making Florida Schools Safer, examines how Alyssa's Law and panic button technology are creating safer environments to learn and work. 

Key Points: 
  • The report, Alyssa's Law: Making Florida Schools Safer , examines how Alyssa's Law and panic button technology are creating safer environments to learn and work.
  • Named in honor of Marjory Stoneman Douglas High School shooting victim Alyssa Alhadeff, Alyssa's Law requires public elementary and secondary schools to be equipped with "silent panic alarms directly linked to law enforcement."
  • CrisisAlert is a wearable panic button that enables staff to request assistance from anywhere on campus without the need for cellular or Wi-Fi service.
  • Key findings from the report include:
    The report includes stories of emergencies in which using the wearable mobile panic button helped to save lives.

Mindpath Health releases Holiday Hangover: Why Dry January May Be Right for You

Retrieved on: 
Wednesday, January 10, 2024

You've probably heard of Dry January if you've been on social media in the last ten years.

Key Points: 
  • You've probably heard of Dry January if you've been on social media in the last ten years.
  • Though plenty of apps help track your progress, Dry January is as low-tech as you want it to be.
  • This article was written by Andrew Monasterio, PMHNP-BC, DNP, a board-certified psychiatric nurse practitioner with Mindpath College Health in Isla Vista, California.
  • Mindpath Health is a leading provider of high-quality outpatient behavioral health services, offering in-person and telehealth visits.

Human medicines European public assessment report (EPAR): Mysimba, naltrexone,bupropion, Date of authorisation: 26/03/2015, Revision: 26, Status: Authorised

Retrieved on: 
Tuesday, January 9, 2024

Human medicines European public assessment report (EPAR): Mysimba, naltrexone,bupropion, Date of authorisation: 26/03/2015, Revision: 26, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Mysimba, naltrexone,bupropion, Date of authorisation: 26/03/2015, Revision: 26, Status: Authorised